What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Arnulf Stenzl mainly investigates Surgery, Bladder cancer, Urology, Prostate cancer and Internal medicine.
His Surgery research includes themes of Cystectomy, Urinary system, Cystoscopy and Lymph node.
His studies examine the connections between Bladder cancer and genetics, as well as such issues in Urinary bladder, with regards to Anastomosis and Urine.
The Urology study combines topics in areas such as Survival rate, Clinical endpoint, Randomized controlled trial, Carcinoma and Primary tumor.
His Prostate cancer study integrates concerns from other disciplines, such as Biopsy and Prostate.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Oncology.
His most cited work include:
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival (651 citations)
- Treatment of muscle-invasive and metastatic bladder cancer: Update of the EAU guidelines (563 citations)
- Generation of pluripotent stem cells from adult human testis (452 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Surgery, Oncology, Urology and Bladder cancer.
His work investigates the relationship between Internal medicine and topics such as Pathology that intersect with problems in Metastasis.
His study in the field of Urethra, Urinary bladder and Perioperative is also linked to topics like In patient.
His Oncology research is multidisciplinary, incorporating perspectives in Androgen deprivation therapy and Disease.
Urology and Urinary system are frequently intertwined in his study.
Arnulf Stenzl studies Cystectomy, a branch of Bladder cancer.
He most often published in these fields:
- Internal medicine (30.18%)
- Surgery (28.60%)
- Oncology (21.35%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (30.18%)
- Prostate cancer (19.45%)
- Oncology (21.35%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Prostate cancer, Oncology, Bladder cancer and Enzalutamide.
His work on Disease, Pembrolizumab, Nephrology and Renal cell carcinoma as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
Arnulf Stenzl undertakes interdisciplinary study in the fields of In patient and Surgery through his research.
His Prostate cancer research incorporates themes from Cancer research, Prostate and Radiology.
His Oncology study combines topics in areas such as Immune checkpoint, Immunotherapy, Liquid biopsy, Castration resistant and Prostate-specific antigen.
His research in Bladder cancer intersects with topics in Chemotherapy, Cystoscopy and Urology.
Between 2017 and 2021, his most popular works were:
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer (167 citations)
- European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. (83 citations)
- Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. (80 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Arnulf Stenzl mainly focuses on Internal medicine, Bladder cancer, Prostate cancer, Oncology and Cancer research.
His work deals with themes such as Cystoscopy and Urology, which intersect with Bladder cancer.
His biological study spans a wide range of topics, including Stage and Radiology.
Arnulf Stenzl combines subjects such as Immune checkpoint, Chemotherapy, Cisplatin, Liquid biopsy and Disease with his study of Oncology.
His Cancer research research incorporates elements of Cancer, DNA methylation, Clear cell renal cell carcinoma, Metabolomics and Peripheral blood mononuclear cell.
His research in Urinary diversion tackles topics such as Surgery which are related to areas like Stem cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
